casimersen: Clinical Trials

1 trial of casimersen, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow casimersen: new trials by email Literature Review of casimersen trials Research Report on casimersen

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy
Casimersen, Golodirsen - Duchenne Muscular Dystrophy
Phase 3TerminatedSarepta Therapeutics, Inc.1712018-08-022024-09-19

Conditions studied

Muscular Dystrophy, Duchenne (1)

Sponsors

Sarepta Therapeutics, Inc. (1)

Countries

Belgium (1)  ·  Bulgaria (1)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Poland (1)  ·  Spain (1)  ·  Sweden (1)  ·  United Kingdom (1)  ·  United States (1)

NIH funding

2017 (1)